SymBio Pharmaceuticals Limited (TYO:4582)

SymBio Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,615	3,963	6,517	6,282	3,860	3,849
Cash & Short-Term Investments	3,615	3,963	6,517	6,282	3,860	3,849
Cash Growth	-44.77%	-39.19%	3.74%	62.74%	0.30%	-1.59%
Accounts Receivable	211.66	423	913	2,084	2,148	406.99
Other Receivables	-	-	-	-	-	314.76
Receivables	211.66	423	913	2,084	2,148	721.75
Inventory	256.58	238	232	469	385.68	944.92
Prepaid Expenses	137.5	110	119	209	145.01	80.65
Other Current Assets	407.56	190	301	268	209.53	219.35
Total Current Assets	4,628	4,924	8,082	9,312	6,748	5,815
Property, Plant & Equipment	-	-	-	69	83.64	76.7
Long-Term Investments	0.02	44	87	85	-	-
Other Intangible Assets	-	-	-	222	259.1	301.84
Long-Term Deferred Tax Assets	1.85	-	-	744	1,276	-
Other Long-Term Assets	37.35	-	1	1	86.66	80.87
Total Assets	4,667	4,968	8,170	10,433	8,453	6,275
Accounts Payable	452.8	-	-	46	69.68	665.46
Accrued Expenses	-	-	-	-	516.04	-
Current Income Taxes Payable	62.15	737	872	1,564	383.6	81.93
Current Unearned Revenue	-	-	-	-	-	192.71
Other Current Liabilities	49.61	29	84	313	548.79	675.25
Total Current Liabilities	564.56	766	956	1,923	1,518	1,615
Long-Term Debt	700	-	-	-	-	-
Other Long-Term Liabilities	0	3	1	2	186.44	0
Total Liabilities	1,269	773	960	1,928	1,707	1,617
Common Stock	18,588	18,336	17,952	17,548	17,158	17,045
Additional Paid-In Capital	18,563	18,311	17,927	17,523	17,133	17,019
Retained Earnings	-34,007	-32,685	-28,852	-26,889	-27,978	-30,010
Treasury Stock	-89.87	-89	-89	-88	-86.05	-17.54
Comprehensive Income & Other	343.82	322	272	411	519.1	620.14
Shareholders' Equity	3,398	4,195	7,210	8,505	6,746	4,657
Total Liabilities & Equity	4,667	4,968	8,170	10,433	8,453	6,275
Total Debt	700	-	-	-	-	-
Net Cash (Debt)	2,915	3,963	6,517	6,282	3,860	3,849
Net Cash Growth	-55.47%	-39.19%	3.74%	62.74%	0.30%	-1.59%
Net Cash Per Share	63.18	87.88	163.32	158.62	99.38	116.80
Filing Date Shares Outstanding	48.71	47.83	44.75	39.52	38.37	38.17
Total Common Shares Outstanding	48.71	45.84	42.19	39.52	38.37	38.17
Working Capital	4,064	4,158	7,126	7,389	5,230	4,200
Book Value Per Share	69.77	91.52	170.89	215.22	175.78	122.01
Tangible Book Value	3,398	4,195	7,210	8,283	6,487	4,355
Tangible Book Value Per Share	69.77	91.52	170.89	209.60	169.03	114.10
Buildings	-	-	-	-	64.62	59.12
Machinery	-	-	-	-	72.73	90.04

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.